Administration of a renin inhibitor in three patients with dense deposit disease (DDD), a rare kidney disease characterized by complement hyperactivation, decreased plasma C3a and C5a levels and complement deposition in the renal biopsy (Bekassy et al., 2018). Here, C3 is linked to kidney disorder.